Brand-name drug
Incruse price, strengths & recalls
Brand of umeclidinium (generic)
Pharmacies pay $11.30 for 1 inhaler of Incruse 0.0625 mg/actuation, 30 actuation inhaler (dry powder) this week, and from $10.27 to $11.30 across its 2 priced strengths and forms. The generic, umeclidinium, costs pharmacies from $7.26. Its official label last changed on May 20, 2026.
Brand- Fair cash price
- $23.50
- Strengths
- 2
- Makers
- 1
- Updated
- Nov 11
Incruse price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 0.0625 mg/actuation, 30 actuation inhaler (dry powder) Brand | $11.30 | $11.30 / 1 inhaler |
| 0.0625 mg/actuation, 7 actuation inhaler (dry powder) Brand | $10.27 | $10.27 / 1 inhaler |
Incruse vs generic umeclidinium
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
| Strength | Brand | Generic | Brand costs |
|---|---|---|---|
| 0.0625 mg/actuation, 30 actuation inhaler (dry powder) | $11.30 | $7.26 | 1.6x |
Supply status: shortages & recalls
What people paid for Incruse
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use INCRUSE ELLIPTA safely and effectively. See full prescribing information for INCRUSE ELLIPTA.INCRUSE ELLIPTA (umeclidinium inhalation powder), for oral inhalation useInitial U.S. Approval: 2013
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA205382 · Glaxo Grp England
- First approved
- April 30, 2014 (12 years ago)
- Latest approved change
- December 13, 2023
- Approved label
- PDF, Dec 14, 2023
- Generic makers
- None on the market
- Last patent listed
- December 18, 2027
Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.
Incruse questions
How much does incruse cost without insurance?
Pharmacies pay about $11.30 for 1 inhaler of incruse 0.0625 mg/actuation, 30 actuation inhaler (dry powder) ($11.30 per unit). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $23.50. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Incruse?
Yes: umeclidinium. Pharmacies pay from $7.26 for it. Compare umeclidinium prices.
Is incruse in shortage?
No shortage is reported for incruse right now. We check the national shortage list every day.
Has incruse been recalled?
No recalls are on record for incruse.
When did the incruse label last change?
The official label was last updated on May 20, 2026 (version 27). See what changed.
Talk about incruse
No comments yet. Questions, tips, what worked for you - start the conversation.